These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1195 related items for PubMed ID: 10189127

  • 21. Expression of cancer-testis antigen (CTA) genes in intrahepatic cholangiocarcinoma.
    Utsunomiya T, Inoue H, Tanaka F, Yamaguchi H, Ohta M, Okamoto M, Mimori K, Mori M.
    Ann Surg Oncol; 2004 Oct; 11(10):934-40. PubMed ID: 15466353
    [Abstract] [Full Text] [Related]

  • 22. [Expression and clinical significance of hepatocellular cancer antigen genes in human hepatocellular carcinoma].
    Wang WX, Leng XS, Peng JR, Mu DC, Wang Y, Zhu JY, Du RY, Chen WF.
    Zhonghua Wai Ke Za Zhi; 2003 Jul; 41(7):506-8. PubMed ID: 12921655
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Detection of AFPmRNA and melanoma antigen gene-1mRNA as markers of disseminated hepatocellular carcinoma cells in blood.
    Yang SZ, Dong JH, Li K, Zhang Y, Zhu J.
    Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):227-33. PubMed ID: 15908320
    [Abstract] [Full Text] [Related]

  • 25. 5' CpG island methylation analysis identifies the MAGE-A1 and MAGE-A3 genes as potential markers of HCC.
    Qiu G, Fang J, He Y.
    Clin Biochem; 2006 Mar; 39(3):259-66. PubMed ID: 16516880
    [Abstract] [Full Text] [Related]

  • 26. Expression of cancer/testis (CT) antigens in Chinese hepatocellular carcinoma and its correlation with clinical parameters.
    Peng JR, Chen HS, Mou DC, Cao J, Cong X, Qin LL, Wei L, Leng XS, Wang Y, Chen WF.
    Cancer Lett; 2005 Mar 10; 219(2):223-32. PubMed ID: 15723723
    [Abstract] [Full Text] [Related]

  • 27. Expression of MAGE genes in esophageal squamous-cell carcinoma.
    Quillien V, Raoul JL, Heresbach D, Collet B, Toujas L, Brasseur F.
    Anticancer Res; 1997 Mar 10; 17(1A):387-91. PubMed ID: 9066682
    [Abstract] [Full Text] [Related]

  • 28. MAGE, BAGE, and GAGE gene expression in patients with esophageal squamous cell carcinoma and adenocarcinoma of the gastric cardia.
    Zambon A, Mandruzzato S, Parenti A, Macino B, Dalerba P, Ruol A, Merigliano S, Zaninotto G, Zanovello P.
    Cancer; 2001 May 15; 91(10):1882-8. PubMed ID: 11346870
    [Abstract] [Full Text] [Related]

  • 29. Expression of A, G and B melanoma antigen genes in human hepatocellular carcinoma.
    Chen Z, Shao JB, Wu W.
    Hepatobiliary Pancreat Dis Int; 2002 Nov 15; 1(4):570-3. PubMed ID: 14607688
    [Abstract] [Full Text] [Related]

  • 30. Expression and immunogenicity of NY-ESO-1 in hepatocellular carcinoma.
    Nakamura S, Nouso K, Noguchi Y, Higashi T, Ono T, Jungbluth A, Chen YT, Old LJ, Nakayama E, Shiratori Y.
    J Gastroenterol Hepatol; 2006 Aug 15; 21(8):1281-5. PubMed ID: 16872310
    [Abstract] [Full Text] [Related]

  • 31. The melanoma antigen gene as a surveillance marker for the detection of circulating tumor cells in patients with breast carcinoma.
    Kwon S, Kang SH, Ro J, Jeon CH, Park JW, Lee ES.
    Cancer; 2005 Jul 15; 104(2):251-6. PubMed ID: 15937912
    [Abstract] [Full Text] [Related]

  • 32. Expression of SSX-1 and NY-ESO-1 mRNA in tumor tissues and its corresponding peripheral blood expression in patients with hepatocellular carcinoma.
    Lu Y, Wu LQ, Lü ZH, Wang XJ, Yang JY.
    Chin Med J (Engl); 2007 Jun 20; 120(12):1042-6. PubMed ID: 17637219
    [Abstract] [Full Text] [Related]

  • 33. Efficient induction of cytotoxic T lymphocytes specific to hepatocellular carcinoma using HLA-A2-restricted MAGE-n peptide in vitro.
    Dong HL, Sui YF, Li ZS, Qu P, Wu W, Ye J, Zhang XM, Lu SY.
    Cancer Lett; 2004 Aug 10; 211(2):219-25. PubMed ID: 15219945
    [Abstract] [Full Text] [Related]

  • 34. Increased mRNA expression of chemokines in hepatocellular carcinoma with tumor-infiltrating lymphocytes.
    Hirano S, Iwashita Y, Sasaki A, Kai S, Ohta M, Kitano S.
    J Gastroenterol Hepatol; 2007 May 10; 22(5):690-6. PubMed ID: 17444857
    [Abstract] [Full Text] [Related]

  • 35. Analysis of differentially expressed genes in human hepatocellular carcinoma using suppression subtractive hybridization.
    Miyasaka Y, Enomoto N, Nagayama K, Izumi N, Marumo F, Watanabe M, Sato C.
    Br J Cancer; 2001 Jul 20; 85(2):228-34. PubMed ID: 11461082
    [Abstract] [Full Text] [Related]

  • 36. Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma.
    Korangy F, Ormandy LA, Bleck JS, Klempnauer J, Wilkens L, Manns MP, Greten TF.
    Clin Cancer Res; 2004 Jul 01; 10(13):4332-41. PubMed ID: 15240519
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Expression of MAGE and GAGE genes in medulloblastoma and modulation of resistance to chemotherapy. Laboratory investigation.
    Kasuga C, Nakahara Y, Ueda S, Hawkins C, Taylor MD, Smith CA, Rutka JT.
    J Neurosurg Pediatr; 2008 Apr 01; 1(4):305-13. PubMed ID: 18377306
    [Abstract] [Full Text] [Related]

  • 39. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L, Xi-Ran Z.
    Hepatogastroenterology; 2004 Apr 01; 51(56):515-25. PubMed ID: 15086194
    [Abstract] [Full Text] [Related]

  • 40. The expression of MAGE and GAGE genes in uterine cervical carcinoma of Korea by RT-PCR with common primers.
    Chang HK, Park J, Kim W, Kim K, Lee M, Park U, Choi B.
    Gynecol Oncol; 2005 May 01; 97(2):342-7. PubMed ID: 15863128
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 60.